KRAS mutation status is not predictive for objective...

Journal of Gastroenterology 2013 / 04 Vol. 48; Iss. 4

KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

Stefan Boeck, Andreas Jung, Rüdiger P. Laubender…
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Language:
english
DOI:
10.1007/s00535-013-0767-4
Date:
April, 2013
File:
PDF, 195 KB
english, 2013
Conversion to is in progress
Conversion to is failed